{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:43:40Z","timestamp":1781660620750,"version":"3.54.5"},"reference-count":48,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005925","name":"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan","doi-asserted-by":"publisher","award":["TCRD-114-041"],"award-info":[{"award-number":["TCRD-114-041"]}],"id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Endothelial dysfunction represents an early indicator of cardiovascular disease in individuals with hypertension. Leptin, an adipokine that regulates vascular homeostasis and metabolism, has been linked to vascular impairment; however, its relationship with vascular reactivity in hypertensive patients remains unclear. Materials and Methods: A cross-sectional study was conducted involving 100 hypertensive patients recruited from the cardiovascular outpatient clinic of Hualien Tzu Chi Hospital between January and July 2021. Clinical profiles, anthropometric data, and laboratory results were collected. Endothelial function was evaluated through digital thermal monitoring, with vascular reactivity index (VRI) classified as poor (&lt;1.0), intermediate (1.0\u20131.9), or good (\u22652.0). The association between serum leptin levels and VRI was examined using correlation analysis, multivariable logistic regression, linear regression, and receiver operating characteristic (ROC) analysis. Results: Of the 100 participants, 10 (10%) exhibited poor VRI, 46 (46%) had intermediate VRI, and 44 (44%) had good VRI. Patients with impaired VRI were significantly older (p = 0.015), had higher waist circumference (p &lt; 0.001), and showed higher serum leptin concentrations (p &lt; 0.001). Multivariable logistic regression identified leptin as an independent factor associated with vascular reactivity dysfunction (OR = 1.096, 95% CI: 1.025\u20131.171, p = 0.007) and poor vascular reactivity (OR = 1.197, 95% CI: 1.034\u20131.387, p = 0.016). Serum leptin levels were negatively correlated with VRI (r = \u22120.408, p &lt; 0.001), and stepwise linear regression confirmed leptin as an independent determinant of VRI (\u03b2 = \u22120.296, p = 0.001). ROC analysis further demonstrated that leptin could predict vascular reactivity dysfunction (AUC = 0.724, 95% CI: 0.625\u20130.824, p &lt; 0.001) and poor vascular reactivity (AUC = 0.770, 95% CI: 0.606\u20130.932, p = 0.0012). Conclusions: Higher serum leptin levels are independently associated with impaired vascular reactivity in hypertensive patients. Leptin may therefore serve as a potential biomarker for early impairment of vascular reactivity in this population.<\/jats:p>","DOI":"10.3390\/medicina61122132","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:39:43Z","timestamp":1764679183000},"page":"2132","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hyperleptinemia Is a Risk Factor for the Development of Vascular Reactivity Impairment in Patients with Hypertension"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-0979","authenticated-orcid":false,"given":"I-Min","family":"Su","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0588-3366","authenticated-orcid":false,"given":"Li-Liang","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"Division of Critical Care Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hung","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"Division of Cardiology, Buddhist Tzu Chi General Hospital, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-4558","authenticated-orcid":false,"given":"Bang-Gee","family":"Hsu","sequence":"additional","affiliation":[{"name":"School of Medicine, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan"},{"name":"Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wu, X., Sha, J., Yin, Q., Gu, Y., and He, X. (2025). Global burden of hypertensive heart disease and attributable risk factors, 1990\u20132021: Insights from the global burden of disease study 2021. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-99358-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gallo, G., Volpe, M., and Savoia, C. (2021). Endothelial dysfunction in hypertension: Current concepts and clinical implications. Front. Med., 8.","DOI":"10.3389\/fmed.2021.798958"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2840-13-10","article-title":"Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes","volume":"13","author":"Morioka","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.physiol.62.1.413","article-title":"Leptin","volume":"62","author":"Ahima","year":"2000","journal-title":"Annu. Rev. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis","volume":"189","author":"Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref_8","first-page":"269","article-title":"Role of leptin in atherogenesis","volume":"11","author":"Dubey","year":"2006","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2796.1999.00571.x","article-title":"Leptin is associated with increased risk of myocardial infarction","volume":"246","author":"Jansson","year":"1999","journal-title":"J. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1161\/hc5001.101061","article-title":"Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)","volume":"104","author":"Wallace","year":"2001","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"648239","DOI":"10.1155\/2015\/648239","article-title":"Differential effects of leptin and adiponectin in endothelial angiogenesis","volume":"2015","author":"Adya","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/HYPERTENSIONAHA.119.13398","article-title":"Leptin restores endothelial function via endothelial PPAR\u03b3-Nox1-mediated mechanisms in a mouse model of congenital generalized lipodystrophy","volume":"74","author":"Faulkner","year":"2019","journal-title":"Hypertension"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1291\/hypres.25.161","article-title":"Leptin causes vasodilation in humans","volume":"25","author":"Nakagawa","year":"2002","journal-title":"Hypertens. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1291\/hypres.26.147","article-title":"Leptin causes nitric-oxide independent coronary artery vasodilation in humans","volume":"26","author":"Matsuda","year":"2003","journal-title":"Hypertens. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2337\/diabetes.49.2.293","article-title":"Leptin induces direct vasodilation through distinct endothelial mechanisms","volume":"49","author":"Lembo","year":"2000","journal-title":"Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"H1514","DOI":"10.1152\/ajpheart.00479.2008","article-title":"Leptin-induced endothelial dysfunction in obesity","volume":"295","author":"Korda","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"H48","DOI":"10.1152\/ajpheart.01159.2004","article-title":"Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction","volume":"289","author":"Knudson","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/oby.2003.108","article-title":"High serum leptin is associated with attenuated coronary vasoreactivity","volume":"11","author":"Sundell","year":"2003","journal-title":"Obes. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.atherosclerosis.2013.03.018","article-title":"Leptin and endothelial function in the elderly: The prospective investigation of the vasculature in Uppsala seniors (PIVUS) study","volume":"228","author":"Gonzalez","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbrc.2016.10.079","article-title":"Leptin promotes endothelial dysfunction in chronic kidney disease through AKT\/GSK3\u03b2 and \u03b2-catenin signals","volume":"480","author":"Ding","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/21623945.2020.1764799","article-title":"Serum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3-5","volume":"9","author":"Lu","year":"2020","journal-title":"Adipocyte"},{"key":"ref_22","first-page":"1348028","article-title":"New indices of endothelial function measured by digital thermal monitoring of vascular reactivity: Data from 6084 patients registry","volume":"2016","author":"Naghavi","year":"2016","journal-title":"Int. J. Vasc. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1475-097X.2011.01037.x","article-title":"Reproducibility and variability of digital thermal monitoring of vascular reactivity","volume":"31","author":"Ahmadi","year":"2011","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jch.14115","article-title":"Digital thermal monitoring techniques to assess vascular reactivity following finger and brachial occlusions","volume":"23","author":"Heath","year":"2020","journal-title":"J. Clin. Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/CS20100476","article-title":"Aging and vascular endothelial function in humans","volume":"120","author":"Seals","year":"2011","journal-title":"Clin. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/tcmj.tcmj_284_24","article-title":"Endothelial dysfunction in chronic kidney disease: Mechanisms, biomarkers, diagnostics, and therapeutic strategies","volume":"37","author":"Wang","year":"2025","journal-title":"Tzu Chi Med. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21525","DOI":"10.3390\/ijms141121525","article-title":"Oxidative stress in diabetes: Implications for vascular and other complications","volume":"14","author":"Pitocco","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E947","DOI":"10.1152\/ajpendo.00426.2010","article-title":"Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome","volume":"299","author":"Schinzari","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.metabol.2006.10.026","article-title":"Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus","volume":"56","author":"Tesauro","year":"2007","journal-title":"Metabolism"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/HYPERTENSIONAHA.120.14515","article-title":"Arterial stiffness in aging: Does it have a place in clinical practice? Recent advances in hypertension","volume":"77","author":"Mitchell","year":"2021","journal-title":"Hypertension"},{"key":"ref_31","first-page":"e984","article-title":"Obesity and cardiovascular disease: A scientific statement from the American Heart Association","volume":"143","author":"Poirier","year":"2021","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MNH.0000000000000867","article-title":"Mechanisms of leptin-induced endothelial dysfunction","volume":"32","author":"Mellott","year":"2023","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13098-019-0410-5","article-title":"Oxidative stress and adipokine levels were significantly correlated in diabetic patients with hyperglycemic crises","volume":"11","author":"Li","year":"2019","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2147\/DMSO.S321311","article-title":"Effect of leptin on chronic inflammatory disorders: Insights to therapeutic target to prevent further cardiovascular complication","volume":"14","author":"Dessie","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/j.2040-4603.2021.tb00148.x","article-title":"Preeclampsia: Linking placental ischemia with maternal endothelial and vascular dysfunction","volume":"11","author":"Bakrania","year":"2020","journal-title":"Compr. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Obradovic, M., Sudar-Milovanovic, E., Soskic, S., Essack, M., Arya, S., Stewart, A.J., Gojobori, T., and Isenovic, E.R. (2021). Leptin and obesity: Role and clinical implication. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.585887"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Savova, M.S., Mihaylova, L.V., Tews, D., Wabitsch, M., and Georgiev, M.I. (2023). Targeting PI3K\/AKT signaling pathway in obesity. Biomed. Pharmacother., 159.","DOI":"10.1016\/j.biopha.2023.114244"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Raman, P., and Khanal, S. (2021). Leptin in atherosclerosis: Focus on macrophages, endothelial and smooth muscle cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115446"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e13086","DOI":"10.1111\/obr.13086","article-title":"Endothelin-1 in the pathophysiology of obesity and insulin resistance","volume":"21","author":"Jenkins","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000360837","article-title":"Novel molecular aspects of ghrelin and leptin in the control of adipobiology and the cardiovascular system","volume":"7","year":"2014","journal-title":"Obes. Facts"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Janaszak-Jasiecka, A., P\u0142oska, A., Wiero\u0144ska, J.M., Dobrucki, L.W., and Kalinowski, L. (2023). Endothelial dysfunction due to eNOS uncoupling: Molecular mechanisms as potential therapeutic targets. Cell Mol. Biol. Lett., 28.","DOI":"10.1186\/s11658-023-00423-2"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: Interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"136773","DOI":"10.1016\/j.neulet.2022.136773","article-title":"The arcuate nucleus: A site of synergism between angiotensin II and leptin to increase sympathetic nerve activity and blood pressure in rats","volume":"785","author":"Shi","year":"2022","journal-title":"Neurosci. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2019.11.044","article-title":"Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review","volume":"75","author":"Mechanick","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s40279-018-0897-1","article-title":"The effect of chronic exercise training on leptin: A systematic review and meta-analysis of randomized controlled trials","volume":"48","author":"Fedewa","year":"2018","journal-title":"Sports Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1111\/j.1467-789X.2011.00873.x","article-title":"Intermittent versus daily calorie restriction: Which diet regimen is more effective for weight loss?","volume":"12","author":"Varady","year":"2011","journal-title":"Obes. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"111076","DOI":"10.1016\/j.diabres.2023.111076","article-title":"The effect of metformin on adipokines levels: A systematic review and meta-analysis of randomized-controlled trials","volume":"207","author":"Zhao","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ijo.2014.177","article-title":"Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss","volume":"39","author":"Iepsen","year":"2015","journal-title":"Int. J. Obes."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2132\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:18:06Z","timestamp":1764681486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["medicina61122132"],"URL":"https:\/\/doi.org\/10.3390\/medicina61122132","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}